Epione (robot surgeon)

2023: Product Announcement

On September 7, 2023, French company Quantum Surgical announced the release of the Epione robotic surgical platform to remove malignancies in the lungs.

According to estimates, in 2020, more than 2 million new cases of lung cancer were registered worldwide, including about 500 thousand in Europe. Such tumors are one of the main causes of mortality from malignancies in general. The Epione system allows doctors to effectively eliminate unresectable tumors that are particularly difficult to reach because of their size or location.

Quantum Surgical's Epione System

Epione is a robotic percutaneous ablation system that uses an automated manipulator, navigation system and camera. The procedures performed are an alternative to surgery. When using Epione, the needle is inserted through the skin into the tumor to kill it. At the same time, Epione combines all stages of the percutaneous ablation procedure on a single platform: this is planning, targeting a malignant formation, destroying and confirming the result.

The Epione system provides for minimally invasive procedures. In addition to eliminating tumors in the lungs, the robot surgeon can be used to treat malignancies in the abdominal cavity, including the liver, kidneys and pancreas. Overall, as noted, Quantum Surgical offers a new approach to cancer therapy.

Epione's platform has received approval from the U.S. Food and Drug Administration (FDA). In addition, CE certification has been passed: this means that the solution meets the basic requirements of the directives and harmonized standards of the European Union. As of September 2023, more than 200 patients have been operated on with Epione in France and the United States.^[1]

Notes